← FDA Drug Approvals (Drugs@FDA)

DEFINITY

NDA · New Drug Application · Sponsor: LANTHEUS MEDCL · Approved 2001-07-31

Drug application

FDA Application #

NDA021064

Application type

New Drug Application

Brand name

DEFINITY

Generic name

PERFLUTREN

Active ingredients

PERFLUTREN

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

LANTHEUS MEDCL

Manufacturer

Lantheus Medical Imaging, Inc.

First approval

2001-07-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown